- Friday, October 30, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Human Organoid Market by Product (Liver, Kidney, Pancreas, Heart, Lungs & others), By Application (Drug toxicity & efficacy testing, developmental biology, disease pathology, personalized & regenerative medicine, and others), By End User (Pharmaceuticals & biotechnology companies, CROs, Academia& research institutes, and others)and By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa).
Global Human Organoid Market Overview:
An organoid is a precise and simplified version of an organ produced in vitro in 3-D that showcases realistic micro-anatomy. They are adopted from one or a few cells from a tissue, embryonic stem cells, or induced pluripotent stem cells, which can self-organize in 3-D culture owing to their self-renewal and differentiation capacities. Organoids are amenable to any experimental approach that has been developed for cell lines. Applications in experimental biology involve modeling tissue physiology and disease, including hereditary, malignant, and infectious diseases. Biobanks of patient-derived tumor organoids are used in drug development research, and they hold promise for developing personalized and regenerative medicine. Human organoids are stemmed cell-derived 3D culture systems — it is now possible to re-create the architecture and physiology of human organs in remarkable detail. Human organoids provide unique opportunities for the deep study of human disease and complement animal models. Human organoids have used to study infectious diseases, genetic disorders, and cancers through the genetic engineering of human stem cells and directly when organoids are generated from patient biopsy samples.
Global Human Organoid Market Insights
Global Human Organoid market size projected to grow at a CAGR during 2020–2027. The market’s growth can be attributed to factors such as the preclinical testing of drugs with low cost & short span. The process of drug discovery also gets shortened by seeing how drugs interact with organs. Moreover, it opens new approaches to personalized medicine and tissue culturing through which scientists can view how organs form and grow. It provides them with new insights into human development and disease treatment like cystic fibrosis. The ciliated cells that normally remove mucus from the lung are not working properly, and cancer. Furthermore, the rise in demand for drug screening, drug development & discovery, developing alternatives for animal testing models, early detection of drug toxicity, and research activities impact the demand for the global organoid market in the future period. The surge in demand for the organoids on account of the high demand for personalized medicine needs will promulgate the global human organoid market share.
Growth Driver
Growing awareness & preference for organoid model than a human model.
Human Organoid culture has more potential benefits than animal models. They provide more robust and faster outcomes, more accurate representation of human tissue & are more readily accessible than animal models do. The time required to establish a research platform is also faster for the Organoid model than for the animal model as it can establish within few weeks to months with a high success rate. Thus the use of patients-derived Organoid in personalized medicine to provide robust personalized data with drug responses. Due to these benefits, researchers are more focusing on the reduction of animal use in R&D. There are some other factors due to which market growth will increase are rising cases of transplant with increasing investment made by private investors and government bodies. Moreover, the increasing need for drug detection at an early stage to avoid drug toxicity and minimize financial loss is hampering the market growth.
Products Segmental Analysis
The global human organoid market is classified into pancreas, kidney, lung, liver, and others based on product. The live segment accounted for the highest market share in 2019. It is attributable to the increasing number of liver diseases and the growing demand for liver transplants.
Application Segmental Analysis
Based on the application, the global human organoid market is segregated into developmental biology, drug toxicity & efficacy testing, disease pathology, personalized medicine, regenerative medicine, and other applications. The developmental biology segment held a higher revenue share in 2019 and is projected to dominate the human Organoid market by 2027. It is primarily attributed to the large potential of organ development and technology advancement.
The Personalized & regenerative segment will grow with a lucrative growth rate in the forecast period. It is due to the replacement of diseased tissue or organs.
End-User Segmental Analysis
Based on End-user, the global human organoid market is classified into pharmaceuticals & biotechnology companies, CROs, academia, and others. The biotechnology and pharmaceutical companies segment will garner higher market potential by 2027 due to growing government initiatives & regulations for the safety of drugs or characterization of new compounds during drug development activities. Additionally, the growing biopharpharmaceutical industries and increasing demand for safer and more effective drugs are expected to drive the market.
Region Segmental Analysis
By geography, the global human organoid market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is stated to account for a significant share by 2027 in the human Organoid market. The growth in the region can be attributed to the growing awareness of organ transplants in countries like the UK, France, Germany, etc., and also supportive government regulations & investments.
The Asia Pacific is expected to provide significant growth opportunities due to rising health care expenditure and a surge in demand for organ transplants.
Competitor Analysis
Companies such as Thermo Fisher Scientific, InSphero, ZenBio, Corning, Emulate, MIMETAS, Kirkstall, Cyprio, BioIVT, Organovo, Cellink, Kerafast, Biopredic International, and HµrelCorporation are the key players in the global human organoid market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global human organoid product manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to human organoids
- Regulatory bodies
- Suppliers
- Retailers
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that they can specifically target.
Market Modelling
By Product
- Liver
- Kidney
- Pancreas
- Heart
- Others
By Application
- Drug toxicity & efficacy testing
- Developmental biology
- Personalized & Regenerative medicine
- Disease Pathology
- Other application
By End-User
- Academic & Research Institutes
- Pharmaceutical& Biotechnology companies
- CROs
- Others
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global Human Organoid Market Overview
- Market Size & Forecast,2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Market Share & Forecast, 2016-2027
- By Product
- Liver
- Kidney
- Lungs
- Pancreas
- Heart
- Others
- By Application
- Drug toxicity & efficacy testing
- Developmental biology
- Personalized & Regenerative medicine
- Disease Pathology
- Other applications
- By End-User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology companies
- CROs
- Others
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- By Product
- Market Size & Forecast,2016-2027
- North America Human Organoid Market Overview
- North America Human Organoid Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- North America Human Organoid Market Share & Forecast,2016-2027
- By Product
- Liver
- Kidney
- Lungs
- Pancreas
- Heart
- Others
- By Application
- Drug toxicity & efficacy testing
- Developmental biology
- Personalized & Regenerative medicine
- Disease Pathology
- Other applications
- By End-User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology companies
- CROs
- Others
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Human Organoid Market
- By Product
- North America Human Organoid Market Size & Forecast, 2016-2027
- Europe Human Organoid Market Overview
- EuropeHuman Organoid Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Europe Human Organoid Market Share & Forecast,2016-2027
- By Product
- Liver
- Kidney
- Lungs
- Pancreas
- Heart
- Others
- By Application
- Drug toxicity & efficacy testing
- Developmental biology
- Personalized & Regenerative medicine
- Disease Pathology
- Other applications
- By End-User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology companies
- CROs
- Others
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Human Organoid Market
- By Product
- EuropeHuman Organoid Market Size & Forecast, 2016-2027
- Asia Pacific Human Organoid Market Overview
- Asia Pacific Human Organoi Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Asia Pacific Human Organoid Market Share & Forecast, 2016-2027
- By Product
- Liver
- Kidney
- Lungs
- Pancreas
- Heart
- Others
- By Application
- Drug toxicity & efficacy testing
- Developmental biology
- Personalized & Regenerative medicine
- Disease Pathology
- Other applications
- By End-User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology companies
- CROs
- Others
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- By Product
- Asia Pacific Human Organoi Market Size & Forecast, 2016-2027
- Economic Impact Study on Asia Pacific Human Organoid Market
- South America Human Organoid Market Overview
- South America Human Organoid Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- South America Human Organoid Market Share & Forecast,2016-2027
- By Material
- Liver
- Kidney
- Lungs
- Pancreas
- Heart
- Others
- By Application
- Drug toxicity & efficacy testing
- Developmental biology
- Personalized & Regenerative medicine
- Disease Pathology
- Other applications
- By End-User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology companies
- CROs
- Others
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- By Material
- South America Human Organoid Market Size & Forecast, 2016-2027
- Economic Impact Study on South America Human Organoid Market
- The Middle East & Africa Human Organoid Market Overview
- The Middle East & Africa Human Organoid Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- The Middle East & Africa Human Organoid Market Share & Forecast, 2016-2027
- By Product
- Liver
- Kidney
- Lungs
- Pancreas
- Heart
- Others
- By Application
- Drug toxicity & efficacy testing
- Developmental biology
- Personalized & Regenerative medicine
- Disease Pathology
- Other applications
- By End-User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology companies
- CROs
- Others
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of the Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- By Product
- The Middle East & Africa Human Organoid Market Size & Forecast, 2016-2027
- Economic Impact Study on the Middle East & Africa Human Organoid Market
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Thermo Fisher Scientific
- InSphero
- ZenBio
- Corning
- Emulate
- MIMETAS
- Kirkstall
- Cyprio
- BioIVT
- Organovo
- Cellink
- Kerafast
- Biopic International
- Hµrel Corporation
